Review article · 2017 · Open access
Bile Acids in the Treatment of Cardiometabolic Diseases
Annals of Hepatology, 16(Suppl. 1: s3-105.), S43–S52 · Published 28 October 2017 · DOI 10.5604/01.3001.0010.5496
In brief
“Bile Acids in the Treatment of Cardiometabolic Diseases” is a 2017 review article by Libor Vítek, published in Annals of Hepatology. OpenAlex counts 32 citations as of 21 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at Annals of Hepatology.
- Citations
- 32
- Most cited in
- 2022 (5)
- Field-weighted impact
- 0.21
- References
- 96
- Authors
- 1
Abstract
Bile acids (BA), for decades considered only to have fat-emulsifying functions in the gut lumen, have recently emerged as novel cardio-metabolic modulators. They have real endocrine effects, acting via multiple intracellular receptors in various organs and tissues. BA affect energy homeostasis through the modulation of glucose and lipid metabolism, predominantly by activating the nuclear farnesoid X receptor (FXR), as well as the cytoplasmic membrane G protein-coupled BA receptor TGR5 in a variety of tissues; although numerous other intracellular targets of BA are also in play.The roles of BA in the pathogenesis of diabetes, obesity, metabolic syndrome, and cardiovascular diseases are seriously being considered, and BA and their derivatives seem to represent novel potential therapeutics to treat these diseases of civilization.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Vítek, L. (2017). Bile Acids in the Treatment of Cardiometabolic Diseases. Annals of Hepatology, 16(Suppl. 1: s3-105.), S43–S52. https://doi.org/10.5604/01.3001.0010.5496
MLA 9
Vítek, Libor. “Bile Acids in the Treatment of Cardiometabolic Diseases.” Annals of Hepatology, vol. 16, no. Suppl. 1: s3-105., 2017, pp. S43–S52. https://doi.org/10.5604/01.3001.0010.5496.
Chicago
Vítek, Libor. 2017. “Bile Acids in the Treatment of Cardiometabolic Diseases.” Annals of Hepatology 16 (Suppl. 1: s3-105.): S43–S52. https://doi.org/10.5604/01.3001.0010.5496.
Harvard
Vítek, L. (2017) ‘Bile Acids in the Treatment of Cardiometabolic Diseases’, Annals of Hepatology, 16(Suppl. 1: s3-105.), pp. S43–S52. doi:10.5604/01.3001.0010.5496.
IEEE
L. Vítek, “Bile Acids in the Treatment of Cardiometabolic Diseases,” Annals of Hepatology, vol. 16, no. Suppl. 1: s3-105., pp. S43–S52, 2017, doi: 10.5604/01.3001.0010.5496.
BibTeX
@article{vitek2017bile,
title = {{Bile Acids in the Treatment of Cardiometabolic Diseases}},
author = {Vítek, Libor},
journal = {Annals of Hepatology},
year = {2017},
volume = {16},
number = {Suppl. 1: s3-105.},
pages = {S43--S52},
doi = {10.5604/01.3001.0010.5496},
url = {https://doi.org/10.5604/01.3001.0010.5496}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2018 | 1 | |
| 2019 | 4 | |
| 2020 | 2 | |
| 2021 | 3 | |
| 2022 | 5 | |
| 2023 | 5 | |
| 2024 | 5 | |
| 2025 | 4 | |
| 2026 | 3 |
Its field-weighted citation impact is 0.21: it has been cited 0.21 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- bile acids
- cardiometabolic disease
- farnesoid X receptor
- TGR5
- G protein-coupled receptors
- energy homeostasis
- glucose metabolism
- lipid metabolism
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Vítek, L. (2017). Bile Acids in the Treatment of Cardiometabolic Diseases. Annals of Hepatology, 16(Suppl. 1: s3-105.), S43–S52. https://doi.org/10.5604/01.3001.0010.5496
How many times has this paper been cited?
32 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Annals of Hepatology: sign in and open the PDF from this page.
Who wrote this paper?
Libor Vítek.
What is the DOI of this paper?
10.5604/01.3001.0010.5496, permanently at https://doi.org/10.5604/01.3001.0010.5496. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.